STAQ Pharma
STAQ Pharma is a hospital-owned FDA-registered 503B outsourcing facility that produces ready-to-administer sterile compounded medications — syringes, IV bags, nasal sprays, and CSTD kits — for hospitals, health systems, and biopharma partners across the United States.
- Company typePrivate
- Founded2018
- HeadquartersDenver, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What STAQ Pharma does
STAQ Pharma, Inc. is a privately held, hospital-owned FDA-registered 503B outsourcing facility headquartered in Denver, Colorado. Founded in 2017/2018, the company produces ready-to-administer sterile compounded medications — pre-filled syringes, IV bags, nasal sprays, and Closed System Transfer Device (CSTD) kits — for hospitals, integrated health systems, ambulatory surgery centers, and pharmaceutical partners nationwide. Its core technology platform is cGMP-compliant sterile compounding executed through advanced semi-automation systems and a Master Control-based Quality Management System, with two purpose-built facilities in Denver (27,000+ sq ft, ~30,000 units/month) and Columbus, Ohio (approximately five times the Denver footprint, including dedicated hazardous drug capacity for oncology production launched in July 2024).
STAQ's products address critical drug shortages, pediatric formulation gaps, and hazardous drug handling requirements — categories where domestic cGMP-compliant supply has been chronically constrained. Its revenue model is transaction-based B2B sales of compounded sterile pharmaceuticals, augmented by professional services revenue from contract manufacturing partnerships with biopharma sponsors (e.g., IAVI/SK bioscience for an intranasal COVID-19 candidate, Cessatech for pediatric pain drug CT001). Distribution runs through a direct enterprise sales force, a secure online ordering portal, and Premier GPO contracts where the company doubled business over the prior year.
STAQ's ownership and governance structure is a defining feature: approximately eight major U.S. health systems — including Froedtert Health, UNC Health, LCMC Health, University Hospitals, Cincinnati Children's, Children's Hospital Colorado, Yale New Haven Health, and ThedaCare — hold equity and board seats, with a Product Development Committee of hospital pharmacy leaders guiding the product roadmap. This embedded customer-ownership model, combined with partnerships with the FDA, Children's Hospital Association, and Angels for Change under Project PROTECT, institutionalizes STAQ as a domestic shortage-response platform serving over 500,000 pediatric patients in the first six months of one program.
STAQ Pharma firmographics
Firmographics- Name
- STAQ Pharma
- Legal name
- STAQ Pharma, Inc.
- Website
- https://staqpharma.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- STAQ Pharma is a hospital-owned FDA-registered 503B outsourcing facility that produces ready-to-administer sterile compounded medications — syringes, IV bags, nasal sprays, and CSTD kits — for hospitals, health systems, and biopharma partners across the United States.
- Ownership category
- akta.pro rank
STAQ Pharma industry classification
Industry- Product category
- Sterile Compounded Pharmaceuticals (503B Outsourcing)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)
- akta.pro secondary industry
- Compounding Pharmacy & Sterile Prep Workflow Systems (HLACAKAM)
Keywords
Where STAQ Pharma is headquartered
LocationHeadquarters
- HQ city
- Denver
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
STAQ Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Compounded Sterile Pharmaceutical Products: STAQ Pharma generates revenue through the sale of FDA-registered 503B compounded sterile medications including syringes, IV bags, nasal sprays, and CSTD kits. Products are sold directly to hospitals, healthcare systems, and ambulatory surgery centers nationwide.
- Contract Manufacturing Services: Provides fill-finish contract manufacturing services for pharmaceutical partners, including production of intranasal sprays and other drug products for collaborators like IAVI and SK bioscience.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Direct purchase model for healthcare facilities |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
STAQ Pharma product offering
Product offeringCore offering
STAQ Pharma is an FDA-registered 503B outsourcing facility that manufactures and sells ready-to-administer sterile compounded medications—pre-filled syringes, IV bags, nasal sprays, and Closed System Transfer Device (CSTD) kits—to U.S. hospitals, health systems, and ambulatory surgery centers. Production is concentrated on medications affected by critical drug shortages, including pediatric formulations and hazardous oncology drugs, and is performed under cGMP standards across two purpose-built facilities in Denver, CO and Columbus, OH.
Product overview
STAQ Pharma operates as a 503B outsourcing facility offering a comprehensive portfolio of sterile compounded medications. The company produces four main product lines: pre-filled syringes (opioids, anesthetics, sedatives, critical care medications), sterile IV bags (pain management, vasopressors), nasal sprays (Desmopressin Acetate), and CSTD kits for hazardous drug handling (Methotrexate). Their Columbus, Ohio facility is specifically designed for oncology drug production. Products address critical drug shortages for hospitals and healthcare systems nationwide, with a focus on pediatric and hospital-specific dosing needs.
Differentiator
Problem solved
Functional benefit
Products and services
- Sterile Compounded Syringes Pre-filled sterile syringes in various dosages covering opioids (fentanyl, hydromorphone, morphine), anesthetics (ketamine, lidocaine), sedatives (midazolam, dexmedetomidine), and critical care medications (phenylephrine, epinephrine, atropine), sold to hospitals and health systems for direct administration.
- Sterile Compounded IV Bags Ready-to-use sterile IV bags containing pain management medications (ketamine, fentanyl, hydromorphone, ropivacaine) and vasopressors (phenylephrine) in various concentrations and volumes, sold to hospitals and health systems.
- Sterile Compounded Nasal Sprays Sterile nasal spray formulations including Desmopressin Acetate for desmopressin therapy, sold to hospitals and health systems for patient administration.
- Methotrexate PF CSTD Kit Closed System Transfer Device (CSTD) kit for hazardous oncology drug handling, containing Methotrexate 25 mg/mL in a 5 mL syringe with ICU Medical Spinning Spiros adaptor, waste syringe, transfer set, and hazardous waste bag.
- Albuterol Sulfate Inhalation Solution Pre-filled syringes of Albuterol 0.5% inhalation solution (preservative-free) in 15 mg/3 mL and 100 mg/20 mL concentrations for respiratory treatment, sold to hospitals and pediatric facilities.
- Oncology Portfolio Sterile compounded oncology medications including methotrexate, produced in a dedicated hazardous drug facility (Columbus, OH) designed specifically for cancer drug production and sold to hospitals and cancer treatment centers.
- Pharmaceutical Contract Manufacturing Services Fill-finish contract manufacturing services for pharmaceutical and biotechnology partners, including production of intranasal sprays and other sterile drug products, leveraging STAQ Pharma's cGMP facilities, semi-automation, and hazardous drug capabilities.
Quantifiable outcome
- Over 500,000 pediatric patients protected from drug shortages of Potassium Chloride and Sodium Chloride in first 6 months of partnership with Angels for Change
- +2 more outcomes
Companies that use STAQ Pharma
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles2 records
STAQ Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
STAQ Pharma partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and strategic.
- Premier Inc.corePartnership through Premier's 503B Pharmacy Compounding Services GPO program. STAQ Pharma doubled its Premier GPO business over the past year. Partnership addresses compounding challenges including drug shortages, regulatory compliance, and supply chain transparency.
- Angels for ChangecoreNonprofit organization addressing drug shortages through supply chain innovation. Partnership under Project PROTECT to increase domestic manufacturing of critical medicines including Magnesium Sulfate IV bags. Over 500,000 pediatric patients protected from shortages through this partnership.
- CessatechstrategicDanish pediatric biotech company collaborating with STAQ Pharma for production of CT001, a pediatric acute pain management drug. STAQ Pharma and Ventis Pharma collaborating to bring the product to US hospitals.
- IAVIstrategicNonprofit scientific research organization. STAQ Pharma providing support services for production of innovative intranasal spray (IPD-52520) targeting COVID-19. Multi-partner project with SK bioscience and University of Washington's Institute for Protein Design.
- SK biosciencestrategicSouth Korean biotech company collaborating on development of intranasal COVID-19 spray (IPD-52520) with STAQ Pharma handling fill-finish operations.
- FDAcoreRegulatory partnership with FDA to address albuterol shortage. STAQ Pharma working with FDA and Children's Hospital Association to maintain supply of critical respiratory medications.
- Children's Hospital AssociationcorePartnership with Children's Hospital Association to address critical drug shortages. Multiple collaborative initiatives including albuterol shortage response and Project PROTECT.
- Children's Hospital ColoradocorePartnership to supply and maintain continuous albuterol for children's hospitals, addressing pediatric respiratory medication shortages since June 2022.
Scale indicators6 records
Recent moves8 records
Expansion highlights6 records
STAQ Pharma competitors and assessment
Company assessmentDirect peers
- Wells Pharma of Houston: Wells Pharma is an FDA-registered 503B outsourcing facility providing sterile compounded medications to hospitals and surgery centers nationwide. It competes with STAQ in sterile injectable outsourcing with similar product categories and customer base.
- QuVa Pharma: QuVa Pharma is one of the largest FDA-registered 503B outsourcing facilities in the U.S., producing sterile compounded ready-to-administer medications for hospitals. It is the most direct competitor to STAQ in sterile injectable compounding, with similar customer base (hospitals/health systems), similar product formats (pre-filled syringes, IV bags), and similar regulatory positioning.
- Fagron Sterile Services: Fagron operates 503B-registered sterile compounding outsourcing facilities serving hospitals and health systems across the U.S. It is a direct competitor to STAQ in sterile injectable outsourcing, with overlapping product categories (pre-filled syringes, IV bags) and hospital customer base.
- Leiters Health: Leiters (formerly Leiters Compounding) is an FDA-registered 503B outsourcing facility producing sterile compounded preparations for hospital pharmacies. It competes head-to-head with STAQ in pre-filled syringes and IV bags, with overlapping customer types and similar emphasis on cGMP quality and ready-to-use formats.
Regional players
- Equashield: Equashield is a manufacturer of closed system transfer devices (CSTDs) for hazardous drug handling, complementary to STAQ's methotrexate CSTD kit. While not a direct compounder, it represents the supplier ecosystem STAQ integrates with for its hazardous drug product line and a potential partner/competitor in the oncology compounding value chain.
Others
- ICU Medical: ICU Medical supplies the Spinning Spiros CSTD adaptor used in STAQ's methotrexate kit and broader closed-system drug transfer infrastructure. As a medical device supplier in the oncology and hazardous drug handling category that STAQ serves, ICU Medical is a key component partner and adjacent player in the same hospital pharmacy workflow.
- Premier Inc. Premier Inc. is a healthcare performance improvement company and major GPO whose 503B Pharmacy Compounding Services program STAQ participates in. Premier is a channel partner rather than a competitor, but its compounding services portfolio creates an indirect benchmark and potential competitor if Premier expands into direct sourcing or contracting with competing 503B facilities.
Broad incumbents
- Catalent: Catalent is a large global CDMO providing sterile fill-finish and manufacturing services for injectable drug products. As STAQ expands into CDMO services (e.g., for IAVI, Cessatech), Catalent represents a much larger incumbent in the contract sterile injectable manufacturing space that STAQ competes against for biopharma partnerships.
- Thermo Fisher Scientific (Patheon): Thermo Fisher, through its Patheon pharma services business, is a global CDMO leader in sterile injectable manufacturing. It represents a larger incumbent competing for CDMO contracts in the same fill-finish and clinical supply categories that STAQ's CDMO services target.
Emerging players
- Civica Rx: Civica Rx is a nonprofit generic drug company established by hospital systems to address drug shortages and supply chain vulnerabilities. While Civica is a manufacturer rather than a 503B compounder, it shares STAQ's mission of addressing essential drug shortages through domestic, hospital-backed manufacturing and competes for the same hospital procurement budget.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
STAQ Pharma social profiles
Digital presenceSTAQ Pharma compliance and trust
Trust signalCompliance2 records
STAQ Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
STAQ Pharma leadership team
Management profileNumber of profiles
Profiles9 records
STAQ Pharma funding detail
Funding detailFunding overview
Funding rounds7 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
STAQ Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about STAQ Pharma
What does STAQ Pharma do?
STAQ Pharma is an FDA-registered 503B outsourcing facility that manufactures and sells ready-to-administer sterile compounded medications—pre-filled syringes, IV bags, nasal sprays, and Closed System Transfer Device (CSTD) kits—to U.S. hospitals, health systems, and ambulatory surgery centers. Production is concentrated on medications affected by critical drug shortages, including pediatric formulations and hazardous oncology drugs, and is performed under cGMP standards across two purpose-built facilities in Denver, CO and Columbus, OH.
Is STAQ Pharma a public or private company?
STAQ Pharma is a private company. It is classified as venture growth investor backed and is currently operating.
When was STAQ Pharma founded?
STAQ Pharma was founded in 2018. It employs 51 to 100 people.
Where is STAQ Pharma based?
STAQ Pharma is headquartered in Denver, United States, in the North America region.
How does STAQ Pharma make money?
Two revenue lines are on record. Compounded Sterile Pharmaceutical Products are the primary driver. The others are contract Manufacturing Services.
Who are STAQ Pharma's main competitors?
Direct peers on record are Wells Pharma of Houston, QuVa Pharma, Fagron Sterile Services and Leiters Health. Equashield is listed as a regional player. Others are ICU Medical and Premier Inc.. Broad incumbents are Catalent and Thermo Fisher Scientific (Patheon). Civica Rx is listed as an emerging player.
Does STAQ Pharma have an API?
No public API is recorded for STAQ Pharma.
What industry is STAQ Pharma in?
STAQ Pharma's product category is Sterile Compounded Pharmaceuticals (503B Outsourcing). Its primary akta.pro industry code is HLAFALAE, Compounding Pharmacies (Sterile/Non-Sterile), with a secondary code of HLACAKAM, Compounding Pharmacy & Sterile Prep Workflow Systems. Its NAICS code is 325412 and its SIC code is 2834.